Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Davidson

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
JAMA Cardiology|May 4, 2017
Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and RegistryNirat Beohar, Darshan Doshi, Vinod Thourani, et al.
ACS Omega|September 13, 2021
Blind Spot: A Braille Patterned Novel Multiplex Lateral Flow Immunoassay Sensor Array for the Detection of Biothreat AgentsE Randal Hofmann, Charles Davidson, Hsiu Chen, et al.
Structural Heart : the Journal of the Heart Team|March 14, 2024
Cardiac Structural and Functional Remodeling After Transcatheter Mitral Valve in Valve Implantation: Early Changes and Prognostic SignificanceGloria Ayuba, Zhiying Meng, Abigail S Baldridge, et al.
Journal of the American College of Cardiology|November 24, 2024
Transcatheter Tricuspid Valve ReplacementJörg Hausleiter, Lukas Stolz, Philipp Lurz, et al.
Circulation. Cardiovascular Interventions|July 22, 2024
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk PatientsS Chris Malaisrie, Mayra Guerrero, Charles Davidson, et al.
JACC. Cardiovascular Interventions|March 25, 2026
Frequency and Outcomes of Acute Hemodynamic Instability Following Transcatheter Tricuspid Valve Replacement: Insights From the CESAR-TR-RegistryJohannes Kirchner, Max Potratz, Muhammed Gercek, et al.
Circulation Research|July 9, 2011
Intramyocardial, autologous CD34+ cell therapy for refractory anginaDouglas W Losordo, Timothy D Henry, Charles Davidson, et al.
Cell Transplantation|May 7, 2016
Autologous CD34<sup>+</sup> Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI StudyTimothy D Henry, Gary L Schaer, Jay H Traverse, et al.
The American Journal of Medicine|May 23, 2023
Multidisciplinary Center Care for Long COVID Syndrome-A Retrospective Cohort StudyJoseph Bailey, Bianca Lavelle, Janet Miller, et al.
Journal of the American College of Cardiology|November 12, 2013
Prospective multicenter evaluation of the direct flow medical transcatheter aortic valveJoachim Schofer, Antonio Colombo, Silvio Klugmann, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JAMA Cardiology|May 4, 2017
Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and RegistryNirat Beohar, Darshan Doshi, Vinod Thourani, et al.
ACS Omega|September 13, 2021
Blind Spot: A Braille Patterned Novel Multiplex Lateral Flow Immunoassay Sensor Array for the Detection of Biothreat AgentsE Randal Hofmann, Charles Davidson, Hsiu Chen, et al.
Structural Heart : the Journal of the Heart Team|March 14, 2024
Cardiac Structural and Functional Remodeling After Transcatheter Mitral Valve in Valve Implantation: Early Changes and Prognostic SignificanceGloria Ayuba, Zhiying Meng, Abigail S Baldridge, et al.
Journal of the American College of Cardiology|November 24, 2024
Transcatheter Tricuspid Valve ReplacementJörg Hausleiter, Lukas Stolz, Philipp Lurz, et al.
Circulation. Cardiovascular Interventions|July 22, 2024
One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk PatientsS Chris Malaisrie, Mayra Guerrero, Charles Davidson, et al.
JACC. Cardiovascular Interventions|March 25, 2026
Frequency and Outcomes of Acute Hemodynamic Instability Following Transcatheter Tricuspid Valve Replacement: Insights From the CESAR-TR-RegistryJohannes Kirchner, Max Potratz, Muhammed Gercek, et al.
Circulation Research|July 9, 2011
Intramyocardial, autologous CD34+ cell therapy for refractory anginaDouglas W Losordo, Timothy D Henry, Charles Davidson, et al.
Cell Transplantation|May 7, 2016
Autologous CD34<sup>+</sup> Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI StudyTimothy D Henry, Gary L Schaer, Jay H Traverse, et al.
The American Journal of Medicine|May 23, 2023
Multidisciplinary Center Care for Long COVID Syndrome-A Retrospective Cohort StudyJoseph Bailey, Bianca Lavelle, Janet Miller, et al.
Journal of the American College of Cardiology|November 12, 2013
Prospective multicenter evaluation of the direct flow medical transcatheter aortic valveJoachim Schofer, Antonio Colombo, Silvio Klugmann, et al.
Pageof 4